The Effect of Low Oxygen Tension on the Early Development of Human Embryo in IVF/ICSI
NCT ID: NCT01983696
Last Updated: 2013-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2013-11-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A series of observational measurement(embryo quality and outcomes of pregnancy) will be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5% oxygen
the oocytes and embryos are cultured in 5% oxygen concentration after oocytes retrieval until Day 6 (counting from fertilization)
5% oxygen concentration
the oocytes and embryos are cultured in the incubator with concentrations of 6% CO2,5%O2, and 89% N2
20% oxygen
the oocytes and embryos are cultured in 20% oxygen concentration (in atmosphere) after oocytes retrieval until Day 6(counting from fertilization)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5% oxygen concentration
the oocytes and embryos are cultured in the incubator with concentrations of 6% CO2,5%O2, and 89% N2
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 10 oocytes after oocyte retrieval
Exclusion Criteria
* PGD/PGS cycles
* half-ICSI/rescure ICSI
* fluid in the uterine cavity, abnormal endometrium, uterine abnormalities,pelvic inflammation
* acute maternal problems.
* One or both spouses have an abnormal karyotype (including polymorphism)
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanxi Provincial Maternity and Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shi Wenhao
Assisted Reproductive Technology Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenhao Shi, Master
Role: STUDY_DIRECTOR
Maternal and Children Health Care Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternal and Child Health Care Hospital
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wenhao Shi, Master
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCHC-2013-02
Identifier Type: -
Identifier Source: org_study_id